COPD & Stem Cell Treatments

TELEMERES AND LONGEVITY

Longevity appears to be controlled at the end of the chromosomes by a section called telomeres. The telomeres contain subunits of DNA that initially contain about 10,000 bases at birth that gradually decreases in length to a point where senility starts and terminates in death.

Research has developed an agent that activates the enzyme telomerase which is believed to increase telomere length. This agent is derived from the root of the plant Astragalus. The condition of the telomeres is a reflection on the status of the cells. Healthy telomere; healthy cells. However, as cells continue to divide the telomeres get shorter. As one reaches the 70s and 80s or develop a serious chronic disease the telomeres will become very short ; cell division slows up and death may soon follow.

Scientists for many years have been working with an enzyme called telomerase in an attempt to immortalize human cells. In laboratory cultures telomerase has been able to maintain longevity in all types of cells such as colon, skin, retina and breast.

The hope is to possibly increase longevcity and slow down the aging process and possibly reverse the effects of serious debilitating diseases.

The doctor and patient must evaluate the risk/benefit of using such an agent to increase the length of telomeres. It will take many more years of research to determine the efficacy of such treatment. The patient who is over the age of fifty years or the very elderly facing death might be considered potential candidates for such treatment when they are fully informed. Younger patients faced with the onset of a serious chronic disease (heart disease, COPD, diabetes type 1, chronic kidney disease, Crohn’s disease, ulcerative colitis, Parkinson, Alzheimer’s, ALS, multiple sclerosis) could be also candidates for this therapy.

The medication can be taken by mouth. In some cases the patient’s cells could be cultured with a gene for telomerase and then re-administered into the patient for a short term therapy.

Persons interested in getting further information about telomeres/telomerase and cost of treatment should contact us by e-mail at info@stemcellregenmed.com or by calling 1-888-620-0411


		TELEMERES AND LONGEVITY Longevity appears to be controlled at the end of the chromosomes by a section called telomeres. The telomeres contain subunits of DNA that initially contain about 10,000 bases at birth that gradually decreases in length to a point where senility starts and terminates in death. Research has developed an agent that activates the enzyme telomerase which is believed to increase telomere length. This agent is derived from the root of the plant Astragalus. The condition of the telomeres is a reflection on the status of the cells. Healthy telomere; healthy cells. However, as cells continue to divide the telomeres get shorter. As one reaches the 70s and 80s or develop a serious chronic disease the telomeres will become very short ; cell division slows up and death may soon follow. Scientists for many years have been working with an enzyme called telomerase in an attempt to immortalize human cells. In laboratory cultures telomerase has been able to maintain longevity in all types of cells such as colon, skin, retina and breast. The hope is to possibly increase longevcity and slow down the aging process and possibly reverse the effects of serious debilitating diseases. The doctor and patient must evaluate the risk/benefit of using such an agent to increase the length of telomeres. It will take many more years of research to determine the efficacy of such treatment. The patient who is over the age of fifty years or the very elderly facing death might be considered potential candidates for such treatment when they are fully informed. Younger patients faced with the onset of a serious chronic disease (heart disease, COPD, diabetes type 1, chronic kidney disease, Crohn’s disease, ulcerative colitis, Parkinson, Alzheimer’s, ALS, multiple sclerosis) could be also candidates for this therapy. The medication can be taken by mouth. In some cases the patient’s cells could be cultured with a gene for telomerase and then re-administered into the patient for a short term therapy. Persons interested in getting further information about telomeres/telomerase and cost of treatment should contact us by e-mail at info@stemcellregenmed.com or by calling 1-888-620-0411 Medical Disclaimer: Treatments discussed on this website are experimental and have not been approved by the FDA. No guarantees are made regarding the results of these treatments. Prospective patients are advised to discuss the use of a Stem Cell treatment for their disease with their physician.